Similarly, it is well established that the upregulation of podoplanin expression in subsets of activated stromal cells appears to be a general response during inflammation and cancer; however, the contribution of podoplanin to the pathogenicity of many inflammatory diseases and types of cancer is controversial. The gene discussed is PDPN; the disease is cancer.